200 related articles for article (PubMed ID: 32357116)
1. Comparative study of intravenous thrombolysis with rt-PA and urokinase for patients with acute cerebral infarction.
Sun F; Liu H; Fu HX; Zhang S; Qian XD; Li JJ; Zhu YB; Zhang XX; Zhang J; Qiu HP; Kang LL; Hu YJ; Zhao L; Mi YJ; Gao YJ; Dou ZJ; Ma Z
J Int Med Res; 2020 May; 48(5):300060519895352. PubMed ID: 32357116
[TBL] [Abstract][Full Text] [Related]
2. Intraarterial thrombolytic therapy within 3 hours of the onset of stroke.
Bourekas EC; Slivka AP; Shah R; Sunshine J; Suarez JI
Neurosurgery; 2004 Jan; 54(1):39-44; discussion 44-6. PubMed ID: 14683539
[TBL] [Abstract][Full Text] [Related]
3. Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke.
Lee KY; Kim DI; Kim SH; Lee SI; Chung HW; Shim YW; Kim SM; Heo JH
AJNR Am J Neuroradiol; 2004 Oct; 25(9):1470-5. PubMed ID: 15502123
[TBL] [Abstract][Full Text] [Related]
4. Clinical Study of Intravenous, Low-Dose Recombinant Tissue Plasminogen Activator for Acute Cerebral Infarction: Comparison of Treatment within 3 Hours versus 3-4.5 Hours.
Deguchi I; Tanahashi N; Takao M
J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):1033-1040. PubMed ID: 29221968
[TBL] [Abstract][Full Text] [Related]
5. [Effect of intravenous thrombolysis with recombinant tissue type plasminogen activator (rt-PA) in different time windows on acute cerebral infarction patients with atrial fibrillation].
Guo Y; Zhang CH; Wang HY; Lin YN; Wang Y; Sun XP
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(26):2054-8. PubMed ID: 27468616
[TBL] [Abstract][Full Text] [Related]
6. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
7. Low-dose rt-PA may not decrease the incidence of symptomatic intracranial haemorrhage in patients with high risk of symptomatic intracranial haemorrhage.
Liu M; Pan Y; Zhou L; Wang Y
Neurol Res; 2019 May; 41(5):473-479. PubMed ID: 30822264
[TBL] [Abstract][Full Text] [Related]
8. Effect of glycated hemoglobin index and mean arterial pressure on acute ischemic stroke prognosis after intravenous thrombolysis with recombinant tissue plasminogen activator.
Liu SY; Cao WF; Wu LF; Xiang ZB; Liu SM; Liu HY; Pan Y; Nie F; Wu XM; Xie XF
Medicine (Baltimore); 2018 Dec; 97(49):e13216. PubMed ID: 30544380
[TBL] [Abstract][Full Text] [Related]
9. Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis.
Ouriel K; Gray B; Clair DG; Olin J
J Vasc Interv Radiol; 2000 Mar; 11(3):295-8. PubMed ID: 10735422
[TBL] [Abstract][Full Text] [Related]
10. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
[TBL] [Abstract][Full Text] [Related]
11. Intravenous recombinant tissue-type plasminogen activator (rt-PA) and urokinase (UK) in patients with evolving myocardial infarction--a multicenter double-blind, randomized trial in Japan.
Kanemoto N; Goto Y; Hirosawa K; Kawai C; Kimata S; Yui Y; Yamamoto Y
Jpn Circ J; 1991 Mar; 55(3):250-61. PubMed ID: 1903167
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Diffusion-Weighted Imaging (DWI) Apparent Diffusion Coefficient (ADC) in Patients with Hyperacute Cerebral Infarction Receiving rt-PA Intravenous Thrombolytic Therapy.
Sui HJ; Yan CG; Zhao ZG; Bai QK
Med Sci Monit; 2016 Nov; 22():4438-4445. PubMed ID: 27864581
[TBL] [Abstract][Full Text] [Related]
13. Assessing the Clinical Efficacy of Recombinant Tissue Plasminogen Activator on Acute Cerebral Infarction.
Wu T; Li P; Sun D
J Nanosci Nanotechnol; 2020 Dec; 20(12):7781-7786. PubMed ID: 32711658
[TBL] [Abstract][Full Text] [Related]
14. Clinical effect of mechanical fragmentation combined with recombinant tissue plasminogen activator artery thrombolysis on acute cerebral infarction.
Jia XF; Hong Z; Fan JH; Zhang YM
J Biol Regul Homeost Agents; 2016; 30(3):821-826. PubMed ID: 27655505
[TBL] [Abstract][Full Text] [Related]
15. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.
Gore JM; Sloan M; Price TR; Randall AM; Bovill E; Collen D; Forman S; Knatterud GL; Sopko G; Terrin ML
Circulation; 1991 Feb; 83(2):448-59. PubMed ID: 1899364
[TBL] [Abstract][Full Text] [Related]
16. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?
Shaltoni HM; Albright KC; Gonzales NR; Weir RU; Khaja AM; Sugg RM; Campbell MS; Cacayorin ED; Grotta JC; Noser EA
Stroke; 2007 Jan; 38(1):80-4. PubMed ID: 17122433
[TBL] [Abstract][Full Text] [Related]
17. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.
Betts KA; Hurley D; Song J; Sajeev G; Guo J; Du EX; Paschoalin M; Wu EQ
J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1996-2003. PubMed ID: 28689999
[TBL] [Abstract][Full Text] [Related]
18. Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion.
Zaidat OO; Suarez JI; Santillan C; Sunshine JL; Tarr RW; Paras VH; Selman WR; Landis DM
Stroke; 2002 Jul; 33(7):1821-6. PubMed ID: 12105360
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Tissue-Type Plasminogen Activator Study of Wake-Up Ischemic Strokes Guided by Rapid MRI.
Guo C; Bai Q; Zhao Z; Zhang J
Cerebrovasc Dis; 2019; 48(1-2):85-90. PubMed ID: 31587000
[TBL] [Abstract][Full Text] [Related]
20. [Thrombolytic agents, urokinase, tissue-type plasminogen activator and pro-urokinase--their routes of administration and dosage: comparison between intracoronary thrombolysis and intravenous coronary thrombolysis].
Motomiya T
Nihon Rinsho; 2003 Apr; 61 Suppl 4():441-5. PubMed ID: 12735012
[No Abstract] [Full Text] [Related]
[Next] [New Search]
